Ledger.Open graph →
SEC Form D · filed April 2, 2015

aTYR PHARMA INC

Offering
$76.3M
Sold
$76.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Amir C. Nashat · San Diego, CADirectorJohn D. Mendlein · San Diego, CAExec · DirectorPaul C. Schimmel · San Diego, CADirectorAkkaraju C. Srinivas · San Diego, CADirectorDavid C. Weiner · San Diego, CAExecEd C. Penhoet · San Diego, CADirectorFrederic C. Chereau · San Diego, CAExecKathryn C. Falberg · San Diego, CADirectorJames C. Blair · San Diego, CADirectorJohn K. Clarke · San Diego, CADirectorAmir C. Nashat · San Diego, CADirectorPaul C. Schimmel · San Diego, CADirectorAkkaraju C. Srinivas · San Diego, CADirectorJohn D. Mendlein · San Diego, CAExec · DirectorDavid C. Weiner · San Diego, CAExecEd C. Penhoet · San Diego, CADirectorFrederic C. Chereau · San Diego, CAExecKathryn C. Falberg · San Diego, CADirectorJames C. Blair · San Diego, CADirectorJohn K. Clarke · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗